Weider Planning “Total Relaunch” Of Core Brands In 2003
This article was originally published in The Tan Sheet
Executive Summary
Weider Nutrition International will attempt to attract OTC and Rx drug users to its Move Free joint health supplement line as part of a "major relaunch" planned for the first half of 2003, President & CEO Bruce Wood said in a Dec. 19 analysts call
You may also be interested in...
Weider Move Free Relaunch Backed By $12-$15 Mil. Marketing Spend
Weider's Schiff division is promoting its revamped Move Free joint supplement line with a $12 mil. to $15 mil. "comprehensive marketing campaign," the firm announced March 26
Weider Namesake Brand To Feature New Products, Packaging In Late FY ’03
Weider Nutrition International plans to revitalize its Weider brand and focus it more toward "body builder" consumers, the firm said during an Aug. 21 analyst call for the fourth quarter and year ended May 31
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC